Reagents for Glucagon and Incretin Research (R41/R42)
| Jurisdiction: |
Federal
|
| Incentive Type: | Grant Program |
| Industries: |
Research, Food, Health And Safety
|
| Eligible Sector: |
Business
|
| Category: |
Financial Incentive
|
| Time Period: |
FY 2015
|
| Governing Body: | National Institutes of Health |
| What’s it worth?: | Not mentioned |
Administered by The National Institutes of Health (NIH) of the Department of Health and Human Services, this is a Small Business Innovation Technology Transfer Research (STTR) grant opportunity for small business concerns (SBCs), with no more than 500 employees, to work with nonprofit research institutions to conduct food and nutrition health research and development of glucagon and incretin reagents.
Maximum funding is generally $150,000 for Phase 1 of the research project and $1,000,000 for Phase 2, with the potential for 50% more (up to $225,000 in Phase 1 and $1,500,000 in Phase 2) if the additional funding is determined to be justified or necessary. Full application directions for SG424 (R&R) are available at Grants.gov.
Applicants may submit more than one (non-duplicate) application, and early applications, which will be peer reviewed as part of NIH funding protocol, are encouraged. Only U.S. small business concerns may apply. Foreign (non-U.S./ non-domestic) institutions and non-U.S./ non-domestic components of U.S. institutions are not eligible, but foreign components, as specified in the NIH Grants Policy Statement, may be eligible.
